Notably, the metabolic intermediates that have characterized during these studies have the potential to serve as potential biomarkers, not only for diseases such as HSAN1, but may also be highly predictive for the occurrence of neuropathy in diabetic patients [22]. The gene discussed is SPTLC1; the disease is neuropathy.